Allergan’s Ophthalmology Focus Grows Beyond Restasis And Glaucoma

Allergan is building a diverse ophthalmology portfolio with a pipeline of drugs, devices and procedures that could bolster the company’s eye care revenue beyond Restasis and glaucoma medicines.